FAGOX Performance — Fidelity Advisor Growth Opportunities Fund, Class M
Data updated: 2026-07-24
FAGOX returned +15.84% year to date and +41.59% over one year to May 2026. Over one year the fund beat its US Large Growth category average: $100 grew to $142, against $125 for the category. Volatility over the past 12 months was 22.15% a year. In the 12 months to May 2026 the fund took in a net $706.6M, and assets reached $35.28B.
FAGOX Growth of $100
What $100 invested in Fidelity Advisor Growth Opportunities Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | FAGOX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $142 | $125 |
| 3 years (Jun 2023 – May 2026) | $109 | $187 |
| 5 years (Jun 2021 – May 2026) | $37 | $176 |
| Since data start (Sep 2019 – May 2026) | $34 | $274 |
FAGOX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.84% |
| 1 year | +41.59% |
3- and 5-year figures withheld: returns differ from sibling classes.
FAGOX Annual Returns
Calendar-year total returns of Fidelity Advisor Growth Opportunities Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +15.84% |
| 2025 | +13.42% |
| 2024 | −9.75% |
| 2023 | −5.59% |
| 2022 | −59.93% |
| 2021 | −27.63% |
| 2020 | +9.66% |
| 2019 (Sep–Dec) | −3.66% |
FAGOX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.0% | −3.2% | −5.7% | +17.4% | +9.2% | — | — | — | — | — | — | — |
| 2025 | +0.1% | −8.1% | −9.9% | +0.6% | +11.2% | +8.7% | +4.9% | +0.8% | +4.8% | +2.8% | −2.1% | +0.8% |
| 2024 | −1.3% | +5.5% | −0.8% | −7.7% | +3.1% | +2.1% | −6.4% | −0.5% | +0.3% | −2.5% | +2.5% | −3.5% |
| 2023 | +7.0% | −5.2% | +1.2% | −4.4% | +4.3% | +2.2% | +2.9% | −7.3% | −8.6% | −7.0% | +8.4% | +2.5% |
| 2022 | −16.6% | −5.3% | −1.3% | −18.8% | −5.3% | −14.3% | +7.0% | −5.2% | −13.8% | +1.0% | +0.5% | −12.0% |
| 2021 | −1.6% | −1.2% | −5.7% | +2.1% | −5.8% | +3.2% | −3.6% | +0.3% | −8.5% | +2.2% | −7.8% | −4.7% |
| 2020 | −0.8% | −8.3% | −15.7% | +14.8% | +5.7% | +5.1% | +4.5% | +8.2% | −6.9% | −5.7% | +10.4% | +2.3% |
| 2019 | — | — | — | — | — | — | — | — | −6.6% | +1.6% | +2.5% | −1.0% |
FAGOX Risk
Risk measures from monthly returns over Jun 2025 – May 2026.
- 1-year volatility (annualised): 22.15%
- Best month: +17.38% (Apr 2026)
- Worst month: −5.67% (Mar 2026)
FAGOX Fund Flows
Monthly money in and out of Fidelity Advisor Growth Opportunities Fund, from SEC Form N-PORT.
- 12-month net flow: $706.6M
- 12-month gross sales (incl. reinvestments): $8.0B
- Sales ÷ redemptions: 1.10×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $578.7M | $597.7M | −$19.1M |
| Apr 2026 | $649.5M | $570.4M | $79.1M |
| Mar 2026 | $604.7M | $529.7M | $75.1M |
| Feb 2026 | $960.2M | $1.0B | −$68.7M |
| Jan 2026 | $664.7M | $568.0M | $96.7M |
| Dec 2025 | $1.6B | $794.9M | $787.0M |
| Nov 2025 | $507.3M | $451.3M | $56.0M |
| Oct 2025 | $547.8M | $538.0M | $9.8M |
| Sep 2025 | $507.3M | $831.3M | −$324.1M |
| Aug 2025 | $498.5M | $432.4M | $66.1M |
| Jul 2025 | $514.2M | $564.1M | −$49.9M |
| Jun 2025 | $422.4M | $423.9M | −$1.5M |
FAGOX Assets Under Management
Net assets of Fidelity Advisor Growth Opportunities Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $35.28B |
| 2026-02-28 | $29.03B |
| 2025-11-30 | $30.35B |
| 2025-08-31 | $29.00B |
| 2025-05-31 | $25.18B |
| 2025-02-28 | $24.71B |
| 2024-11-30 | $24.94B |
| 2024-08-31 | $22.46B |
| 2024-05-31 | $21.19B |
| 2024-02-29 | $20.28B |
| 2023-11-30 | $17.28B |
| 2023-08-31 | $16.96B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.